Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Trxade Health Q1 EPS $(6.40) Down From $(0.45) YoY

Author: Benzinga Newsdesk | June 27, 2024 08:03am
Trxade Health (NASDAQ:MEDS) reported quarterly losses of $(6.40) per share. This is a 1322.22 percent decrease over losses of $(0.45) per share from the same period last year.

Posted In: MEDS